Ex-vivo perfusion bioassay : an excellent technique to measure the bioactivity of inhalable insulin coated microcrystals by Ross, Alistair et al.
Strathprints Institutional Repository
Ross, Alistair and Stevens, Howard and Partridge, Johann and Moore, Barry and Flores, Maria and
Parker, Marie-Claire and Brown, Amanda J. and Hillier, Chris and Coleman, Jamie (2002) Ex-vivo
perfusion bioassay : an excellent technique to measure the bioactivity of inhalable insulin coated
microcrystals. In: 2002 AAPS Annual Meeting and Exposition, 2002-11-08 - 2002-11-14, Toronto.
Strathprints is designed to allow users to access the research output of the University of Strathclyde.
Copyright c© and Moral Rights for the papers on this site are retained by the individual authors
and/or other copyright owners. You may not engage in further distribution of the material for any
profitmaking activities or any commercial gain. You may freely distribute both the url (http://
strathprints.strath.ac.uk/) and the content of this paper for research or study, educational, or
not-for-profit purposes without prior permission or charge.
Any correspondence concerning this service should be sent to Strathprints administrator:
mailto:strathprints@strath.ac.uk
http://strathprints.strath.ac.uk/
Ex-vivo Perfusion Bioassay: An Excellent Technique to Measure the Bioactivity of
Inhalable Insulin Coated Microcrystals
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1Department of Pharmaceutical Sciences, 2Department of Pure & Applied Chemistry, University of Strathclyde, 3XstalBio,
University of Glasgow, 4Vascular Assessment Unit, Glasgow Caledonian University
Purpose. To measure the bioactivity of inhalable insulin coated microcrystals using a perfusion bioassay that measures its
vasodilatory effect on smooth muscle arterial tissue. Methods. The bioactivity of an insulin protein coated microcrystal
(PCMC), a potential candidate for pulmonary drug delivery and commercial insulin was determined on a Danish Myo Tech
P110 pressure myograph system. 12 week old Mesenteric resistance arteries from Male Wistar rats were isolated and
immersed in a physiological salt solution (PSS) and attached to 2 opposing hollow glass micro-cannula (outer diameter 80
microns). The PSS was gradually warmed to 37°C (at a pressure less than 5mm Hg) for 1hr. Subsequently the pressure was
increased up to 40mm Hg over a period 15 minutes and equilibrated for a further 15 minutes after gassing with 95%O2 /
5%CO2 to achieve a pH of 7.4 at 37°C. After normalisation by two washes of 123mM KCl and exposure to 1-10mM
noradrenaline the arteries were exposed intraluminally to each insulin preparation by gradual infusion directly into the lumen
via a fetal microcannulae inserted to the tip of the glass mounting cannula, at a constant pressure. Results. The preliminary
results (full cummulative response curve yet to be determined) demonstrate insulin mediated relaxation to noradrenaline
preconstriction. The level of constriction drops from 100% to 42% as the concentration of insulin increases from -11 to -9
Log M for the PCMC compared with a drop from 100 % to 65% for the commercial insulin preparation. However the more
potent vasodilatory effect found for the insulin PCMC is more likely to be a result of variance introduced in each dilution
step than a real increase in potency. Conclusion. The perfusion bioassay technique provides an excellent method of
measuring insulin bioactivity and indicates the insulin loaded on the microcrystal support is fully active.
